BEDFORD, Mass., Feb. 8, 2011 /PRNewswire/ — Hologic, Inc.
(Hologic or the Company) (Nasdaq:
HOLX), a leading developer, manufacturer and supplier of
premium diagnostics products, medical imaging systems and surgical
products dedicated to serving the healthcare needs of women, will
focus on new, ready to market technologies in women’s imaging at
the European Congress of Radiology (ECR),
the annual meeting of the European Society of Radiology in Vienna,
Austria, March 4-7.
Hologic will be one of the largest exhibitors at ECR 2011.
Over 19,000 participants from more than 100 countries are
expected to attend.
A major feature of the Hologic exhibit this year is 3D
mammography (breast tomosynthesis) and the Hologic Selenia
Dimensions 3D breast tomosynthesis option. Selenia Dimensions,
the newest imaging platform in the world’s most popular digital
mammography line, directly addresses the primary limitations of 2D
mammography – the superimposition of normal breast
tissue.
Selenia Dimensions systems are installed in more than a dozen
countries and cleared for sale in 40 countries. Selenia Dimensions
delivers the exceptional 2D images the industry has come to expect
from Hologic and, for the first time ever, gives radiologists the
option of offering their patients a conventional 2D digital
mammogram and a 3D tomosynthesis exam – all under one
compression, in just seconds.
Shown for the first time at ECR are two new commercial products
designed specifically for Selenia Dimensions: the Affirm
upright breast biopsy guidance system and ImageChecker 3D
Calc computer-aided detection.
Interest in Selenia Dimensions is unusually high since Hologic
received a U.S. Food and Drug Administration “Approvable Let
‘/>”/>
SOURCE
